| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 737526
[patent_doc_number] => 07034004
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-25
[patent_title] => 'Peptides and methods for the control of obesity'
[patent_app_type] => utility
[patent_app_number] => 10/139624
[patent_app_country] => US
[patent_app_date] => 2002-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6421
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/034/07034004.pdf
[firstpage_image] =>[orig_patent_app_number] => 10139624
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/139624 | Peptides and methods for the control of obesity | May 6, 2002 | Issued |
Array
(
[id] => 1197323
[patent_doc_number] => 06727347
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-27
[patent_title] => 'Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body'
[patent_app_type] => B1
[patent_app_number] => 10/018806
[patent_app_country] => US
[patent_app_date] => 2002-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8821
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/727/06727347.pdf
[firstpage_image] =>[orig_patent_app_number] => 10018806
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/018806 | Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body | May 6, 2002 | Issued |
Array
(
[id] => 544552
[patent_doc_number] => 07163918
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-16
[patent_title] => 'Iodothyronine compositions'
[patent_app_type] => utility
[patent_app_number] => 10/136433
[patent_app_country] => US
[patent_app_date] => 2002-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 18708
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/163/07163918.pdf
[firstpage_image] =>[orig_patent_app_number] => 10136433
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/136433 | Iodothyronine compositions | May 1, 2002 | Issued |
Array
(
[id] => 990780
[patent_doc_number] => 06919307
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-19
[patent_title] => 'Therapeutic agents and methods of use thereof for the modulation of angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 10/138935
[patent_app_country] => US
[patent_app_date] => 2002-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17498
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/919/06919307.pdf
[firstpage_image] =>[orig_patent_app_number] => 10138935
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/138935 | Therapeutic agents and methods of use thereof for the modulation of angiogenesis | May 1, 2002 | Issued |
Array
(
[id] => 1130886
[patent_doc_number] => 06787522
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-09-07
[patent_title] => 'Antibacterial agents'
[patent_app_type] => B2
[patent_app_number] => 10/134754
[patent_app_country] => US
[patent_app_date] => 2002-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27028
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 385
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/787/06787522.pdf
[firstpage_image] =>[orig_patent_app_number] => 10134754
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/134754 | Antibacterial agents | Apr 29, 2002 | Issued |
Array
(
[id] => 7623707
[patent_doc_number] => 06686458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-02-03
[patent_title] => 'Synthetic molecules that specifically react with target sequences'
[patent_app_type] => B2
[patent_app_number] => 10/126752
[patent_app_country] => US
[patent_app_date] => 2002-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11177
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/686/06686458.pdf
[firstpage_image] =>[orig_patent_app_number] => 10126752
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/126752 | Synthetic molecules that specifically react with target sequences | Apr 18, 2002 | Issued |
Array
(
[id] => 6716422
[patent_doc_number] => 20030027770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/125695
[patent_app_country] => US
[patent_app_date] => 2002-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 36168
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027770.pdf
[firstpage_image] =>[orig_patent_app_number] => 10125695
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/125695 | Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof | Apr 17, 2002 | Abandoned |
Array
(
[id] => 7634708
[patent_doc_number] => 06656911
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-12-02
[patent_title] => 'Serine protease inhibitors'
[patent_app_type] => B2
[patent_app_number] => 10/125222
[patent_app_country] => US
[patent_app_date] => 2002-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 33429
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/656/06656911.pdf
[firstpage_image] =>[orig_patent_app_number] => 10125222
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/125222 | Serine protease inhibitors | Apr 17, 2002 | Issued |
Array
(
[id] => 7625338
[patent_doc_number] => 06723831
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-04-20
[patent_title] => 'Neoglycoproteins'
[patent_app_type] => B2
[patent_app_number] => 10/123396
[patent_app_country] => US
[patent_app_date] => 2002-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17828
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/723/06723831.pdf
[firstpage_image] =>[orig_patent_app_number] => 10123396
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/123396 | Neoglycoproteins | Apr 15, 2002 | Issued |
Array
(
[id] => 754552
[patent_doc_number] => 07018980
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-28
[patent_title] => 'Method for preparation of orally administrated insulin formulation'
[patent_app_type] => utility
[patent_app_number] => 10/474474
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1549
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/018/07018980.pdf
[firstpage_image] =>[orig_patent_app_number] => 10474474
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/474474 | Method for preparation of orally administrated insulin formulation | Apr 11, 2002 | Issued |
Array
(
[id] => 1153026
[patent_doc_number] => 06767897
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-27
[patent_title] => 'Therapeutic uses of tri-, tetra-, penta-, and polypeptides'
[patent_app_type] => B2
[patent_app_number] => 10/122246
[patent_app_country] => US
[patent_app_date] => 2002-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20595
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/767/06767897.pdf
[firstpage_image] =>[orig_patent_app_number] => 10122246
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/122246 | Therapeutic uses of tri-, tetra-, penta-, and polypeptides | Apr 10, 2002 | Issued |
Array
(
[id] => 6782574
[patent_doc_number] => 20030064021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Neutrophil stimulating peptides'
[patent_app_type] => new
[patent_app_number] => 10/119621
[patent_app_country] => US
[patent_app_date] => 2002-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9327
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20030064021.pdf
[firstpage_image] =>[orig_patent_app_number] => 10119621
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/119621 | Neutrophil stimulating peptides | Apr 9, 2002 | Abandoned |
Array
(
[id] => 1308388
[patent_doc_number] => 06617435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-09
[patent_title] => 'Method for recovering proteins from the interstitial fluid of plant tissues'
[patent_app_type] => B2
[patent_app_number] => 10/119330
[patent_app_country] => US
[patent_app_date] => 2002-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13123
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/617/06617435.pdf
[firstpage_image] =>[orig_patent_app_number] => 10119330
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/119330 | Method for recovering proteins from the interstitial fluid of plant tissues | Apr 7, 2002 | Issued |
Array
(
[id] => 6865531
[patent_doc_number] => 20030191057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'G-type peptides to ameliorate atherosclerosis'
[patent_app_type] => new
[patent_app_number] => 10/120508
[patent_app_country] => US
[patent_app_date] => 2002-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16833
[patent_no_of_claims] => 115
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191057.pdf
[firstpage_image] =>[orig_patent_app_number] => 10120508
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/120508 | G-type peptides to ameliorate atherosclerosis | Apr 4, 2002 | Issued |
| 09/958049 | Compound for inhibiting the influx of polymorphonuclear leukocytes (pmns) in a tissue, its selection, pharmaceutical compositions and use | Apr 3, 2002 | Abandoned |
Array
(
[id] => 1131724
[patent_doc_number] => 06783539
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-31
[patent_title] => 'Phototriggerable, collagen-crosslinking compounds for wound closure'
[patent_app_type] => B1
[patent_app_number] => 10/113426
[patent_app_country] => US
[patent_app_date] => 2002-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 2641
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/783/06783539.pdf
[firstpage_image] =>[orig_patent_app_number] => 10113426
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/113426 | Phototriggerable, collagen-crosslinking compounds for wound closure | Mar 28, 2002 | Issued |
Array
(
[id] => 7409725
[patent_doc_number] => 20040176300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Indolicidin analogs with anti-microbial activity'
[patent_app_type] => new
[patent_app_number] => 10/106802
[patent_app_country] => US
[patent_app_date] => 2002-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3181
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176300.pdf
[firstpage_image] =>[orig_patent_app_number] => 10106802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/106802 | Indolicidin analogs with anti-microbial activity | Mar 24, 2002 | Issued |
Array
(
[id] => 1093076
[patent_doc_number] => 06825166
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-30
[patent_title] => 'Molecular conjugates for use in treatment of cancer'
[patent_app_type] => B2
[patent_app_number] => 10/107543
[patent_app_country] => US
[patent_app_date] => 2002-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 9802
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/825/06825166.pdf
[firstpage_image] =>[orig_patent_app_number] => 10107543
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/107543 | Molecular conjugates for use in treatment of cancer | Mar 24, 2002 | Issued |
| 10/104489 | Polypeptide useful as antiallergic/antiasthmatic activity, methods for the preparation thereof, pharmaceutical compositions containing such polypeptide and use thereof | Mar 24, 2002 | Abandoned |
Array
(
[id] => 6429514
[patent_doc_number] => 20020127244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Process for fractionating polyethylene glycol (PEG) - protein adducts and an adduct of PEG and granulocyt-macrophage colony stimulating factor'
[patent_app_type] => new
[patent_app_number] => 10/094995
[patent_app_country] => US
[patent_app_date] => 2002-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8883
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20020127244.pdf
[firstpage_image] =>[orig_patent_app_number] => 10094995
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/094995 | Process for fractionating polyethylene glycol (PEG) - protein adducts and an adduct of PEG and granulocyt-macrophage colony stimulating factor | Mar 11, 2002 | Abandoned |